Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $237.09 | 2 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $119.73 | 1 | $0 (2017) |
| Organogenesis Inc. | $117.36 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2017 | $237.09 | 2 | E.R. Squibb & Sons, L.L.C. ($119.73) |
All Payment Transactions
2 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/08/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $119.73 | General |
| Category: Cardiovascular | ||||||
| 04/07/2017 | Organogenesis Inc. | Apligraf (Device) | Food and Beverage | Cash or cash equivalent | $117.36 | General |
| Category: Podiatry | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 36 | 36 | $13,188 | $2,590 |
| 2022 | 7 | 263 | 266 | $49,671 | $12,526 |
| 2021 | 16 | 926 | 929 | $122,069 | $40,974 |
| 2020 | 6 | 183 | 185 | $35,919 | $8,841 |
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 22 | 22 | $9,086 | $1,781 | 19.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 14 | 14 | $4,102 | $809.16 | 19.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 58 | 59 | $24,426 | $5,214 | 21.3% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 84 | 86 | $6,278 | $1,988 | 31.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 29 | 29 | $8,468 | $1,739 | 20.5% |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | Office | 2022 | 24 | 24 | $4,872 | $1,712 | 35.1% |
| 0054A | Adm sarscv2 30mcg trs-sucr b | Office | 2022 | 31 | 31 | $3,937 | $1,254 | 31.8% |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within | Office | 2022 | 23 | 23 | $1,564 | $570.75 | 36.5% |
| 81002 | Urinalysis, manual test | Office | 2022 | 14 | 14 | $126.00 | $48.43 | 38.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 73 | 75 | $25,275 | $7,671 | 30.4% |
| 0004A | Fee covid-19 vac 1 res | Office | 2021 | 128 | 128 | $16,256 | $5,228 | 32.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 63 | 63 | $14,490 | $5,112 | 35.3% |
| 0002A | Adm sarscov2 30mcg/0.3ml 2nd | Office | 2021 | 109 | 109 | $13,843 | $4,452 | 32.2% |
| 0001A | Adm sarscov2 30mcg/0.3ml 1st | Office | 2021 | 103 | 103 | $12,832 | $4,137 | 32.2% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 161 | 161 | $11,270 | $3,738 | 33.2% |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | Office | 2021 | 38 | 38 | $5,282 | $2,850 | 54.0% |
| 0013A | Fee covid-19 vac 2 booster | Office | 2021 | 50 | 50 | $6,350 | $2,043 | 32.2% |
| 0003A | Fee covid-19 vac 1 booster | Office | 2021 | 49 | 49 | $6,223 | $2,001 | 32.2% |
| 0064A | Fee covid-19 vac 7 res | Office | 2021 | 37 | 37 | $4,699 | $1,510 | 32.1% |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within | Office | 2021 | 38 | 38 | $2,584 | $950.00 | 36.8% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 12 | 12 | $1,620 | $783.12 | 48.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 14 | 14 | $616.00 | $243.23 | 39.5% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2021 | 12 | 12 | $384.00 | $126.72 | 33.0% |
| 81002 | Urinalysis, manual test | Office | 2021 | 25 | 25 | $225.00 | $87.00 | 38.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 14 | 15 | $120.00 | $42.00 | 35.0% |
About Dr. Armida Nunez, MD
Dr. Armida Nunez, MD is a Emergency Medicine healthcare provider based in Vancouver, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1104870732.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Armida Nunez, MD has received a total of $237.09 in payments from pharmaceutical and medical device companies, with $237.09 received in 2017. These payments were reported across 2 transactions from 2 companies. The most common payment nature is "Food and Beverage" ($237.09).
As a Medicare-enrolled provider, Nunez has provided services to 1,408 Medicare beneficiaries, totaling 1,416 services with total Medicare billing of $64,931. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Practice Information
- Specialty Emergency Medicine
- Location Vancouver, WA
- Active Since 05/19/2006
- Last Updated 12/14/2020
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1104870732
Products in Payments
- ELIQUIS (Drug) $119.73
- Apligraf (Device) $117.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Vancouver
Peter Mullins
Emergency Medicine — Payments: $3,990
Christopher Finley, Md, MD
Emergency Medicine — Payments: $1,626
Arnold Cha, M.d, M.D
Emergency Medicine — Payments: $1,127
Dr. Charles Pinney, M.d, M.D
Emergency Medicine — Payments: $447.29
Daniel Bissell, Md, MD
Emergency Medicine — Payments: $360.63
Dr. Mark Foster, Md, MD
Emergency Medicine — Payments: $190.50